The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.
Michael M. Vickers
No relevant relationships to disclose
Dongsheng Tu
No relevant relationships to disclose
Chee Lee
No relevant relationships to disclose
Paul Wheatley-Price
No relevant relationships to disclose
Wendy Parulekar
No relevant relationships to disclose
Michael Donald Brundage
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Heather-Jane Au
No relevant relationships to disclose
Christopher J. O'Callaghan
No relevant relationships to disclose
Derek J. Jonker
No relevant relationships to disclose
Jolie Ringash
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose